Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Applying to Rush University Medical Center · Chicago, Illinois
Answer a few short questions to share with the research team.